nonalcoholic%20fatty%20liver%20disease
NONALCOHOLIC FATTY LIVER DISEASE

Nonalcoholic fatty liver disease is having excessive hepatic fat (in the form of triglycerides) accumulation not due to excessive alcohol consumption or other secondary causes.

It is considered as a hepatic manifestation of metabolic syndrome.

Progression of nonalcoholic fatty liver disease is variable.

Nonalcoholic%20fatty%20liver%20disease Patient Education

Lifestyle Modification

  • The only effective treatment for nonalcoholic fatty liver (NAFL) is weight loss
    • It was found that a gradual weight loss of 5-10% has shown improvement in hepatic insulin resistance, liver histology (eg portal inflammation and fibrosis) and enzyme levels
  • Lifestyle modification overall goal is to reduce excess body weight through diet and exercise therapies for a period of 3-12 months
  • To improve NAFL/nonalcoholic steatohepatitis (NASH), it is recommended to prioritize the optimization of energy intake and restrict lipids in terms of the proportions of nutrient intake

Diet

  • It was found that moderate calorie-restricted diet (500-1000 kcal reduction/day) with modified macronutrient composition produces better results in comparison with a very low-caloric diet
  • Avoid beverages and foods that contain fructose and trans-fat
  • Increasing intake of omega-3/omega-6 polyunsaturated fatty acids in diet is suggested

Alcohol Intake

  • Keep alcohol intake below the risk threshold of 30 g for males and 20 g for females
  • Heavy alcohol intake is a risk factor for chronic liver disease and should be avoided by patients with NAFL and NASH

Coffee Drinking

  • Found to have protective element in NAFLD and reduces histological severity and liver-related outcomes

Exercise/Physical Activity

  • Moderate-intensity aerobic physical activities 150-200 minutes/week in 3-5 sessions are recommended
    • Has been shown to improve fatty changes in the liver even without accompanying reduced body weight
  • It was also found that resistance training is also effective as it promotes musculoskeletal fitness with effects on metabolic risk factors
  • Any increase on previous levels of physical activity is better than continuing inactivity
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Audrey Abella, 6 days ago
A pilot telemedicine initiative may be an alternative for facilitating delivery of intravenous iron (IVI) for individuals requiring iron supplementation.